Back to KROS
LOS ANGELES CAPITAL MANAGEMENT LLC → KROS
LOS ANGELES CAPITAL MANAGEMENT LLC KROS Position History
Keros Therapeutics, Inc. • Healthcare
Quarters held
5
Latest value
$797K
Q3 2026
Peak value
$1.9M
First seen
Q4 2025
Dollar value over time
Show data table
| Period | Position value |
|---|---|
| Q4 2025 | $508K |
| Q1 2026 | $1.9M |
| Q2 2026 | $903K |
| Q3 2026 | $797K |
| Q3 2026 | $797K |
Quarter-by-quarter history
Every disclosed snapshot of the position
| Quarter | Value | Shares | % Portfolio | Change |
|---|---|---|---|---|
| Q3 2026 | $797K | 69.9K | — | — |
| Q3 2026 | $797K | 69.9K | — | — |
| Q2 2026 | $903K | 84.4K | — | — |
| Q1 2026 | $1.9M | 172.2K | — | — |
| Q4 2025 | $508K | 33.8K | — | — |